Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
Year-over-year SG&A expense growth
Latest
-6.98%
↓ 180% vs avg
Percentile
P18
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
8.77%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -6.98% |
| Q2 2025 | -9.69% |
| Q1 2025 | 5.41% |
| Q4 2024 | 0.54% |
| Q3 2024 | 4.98% |
| Q2 2024 | -3.40% |
| Q1 2024 | 4.09% |
| Q4 2023 | 1.02% |
| Q3 2023 | -5.59% |
| Q2 2023 | -8.35% |
| Q1 2023 | -32.76% |
| Q4 2022 | 98.55% |
| Q3 2022 | -28.70% |
| Q2 2022 | 18.37% |
| Q1 2022 | -1.40% |
| Q4 2021 | 11.88% |
| Q3 2021 | 8.59% |
| Q2 2021 | 40.08% |
| Q1 2021 | 25.12% |
| Q4 2020 | 69.70% |
| Q3 2020 | -3.42% |
| Q2 2020 | 13.62% |
| Q1 2020 | 0.00% |